Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirine

5 Dec 2024

Abstract excerpt

Increasingly, people attending HIV services are requesting long-acting injectable (LAI) antiretroviral treatment (ART). However, without HIV RNA resistance-associated mutation results, individuals are considered unsuitable for LAI ART. We present our experience of sequencing proviral HIV DNA in 30 individuals to inform suitability for LAI ART, of whom 23 were considered suitable. In conclusion, optimization of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV/AIDS drug development and treatment
Share to HIV/AIDS Research and Interventions
Share to HIV Research and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39639724
DOI: 10.1097/qad.0000000000004040

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proviral HIV DNA sequencing to inform suitability for long-acting injectable cabotegravir/rilpivirinePMID 39639724Read ↗

Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV.Semantic proximity Read ↗

Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?Semantic proximity Read ↗

HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.Semantic proximity Read ↗

European guidelines on the clinical management of HIV-1 tropism testingSemantic proximity Read ↗

Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.Semantic proximity Read ↗

Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug ResistanceSemantic proximity Read ↗

Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation.Semantic proximity Read ↗

HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterizationSemantic proximity Read ↗

Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance.Semantic proximity Read ↗

Virological Failure After Switch to Long-Acting Cabotegravir and Rilpivirine Injectable Therapy: An In-depth Analysis.Semantic proximity Read ↗

HIV DNA Sequencing to Detect Archived Antiretroviral Drug ResistanceSemantic proximity Read ↗

Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.